ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Michigan » General Practice

Top General Practice Prescribers in Michigan

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ANDREW COLMAN DO

General Practice

56,686

$3.02M

1394
1198 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

15%
patients receiving schedule three controlled substances

Avg: 29%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 22%

$53
Average prescription price

Avg: $57

TERRY BAUL M.D.

General Practice

26,518

$1.35M

620
299 are 65+

13%
patients receiving schedule two controlled substances

Avg: 8%

52%
patients receiving schedule three controlled substances

Avg: 29%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 22%

$51
Average prescription price

Avg: $57

SEONG KIM MD, MPM

General Practice

14,064

$733K

331
245 are 65+

9%
patients receiving schedule two controlled substances

Avg: 8%

24%
patients receiving schedule three controlled substances

Avg: 29%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $57

HORACE DAVIS D.O

General Practice

12,835

$911K

394
127 are 65+

20%
patients receiving schedule two controlled substances

Avg: 8%

55%
patients receiving schedule three controlled substances

Avg: 29%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 22%

$71
Average prescription price

Avg: $57

JOSEPH RAMBO M.D.

General Practice

12,563

$624K

386
285 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

5%
patients receiving schedule three controlled substances

Avg: 29%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 22%

$50
Average prescription price

Avg: $57

WALAYAT KHAN M.D.

General Practice

12,436

$713K

373
81 are 65+

47%
patients receiving schedule two controlled substances

Avg: 8%

75%
patients receiving schedule three controlled substances

Avg: 29%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 22%

$57
Average prescription price

Avg: $57

ZONGLI CHANG MD

General Practice

12,114

$938K

358
88 are 65+

19%
patients receiving schedule two controlled substances

Avg: 8%

72%
patients receiving schedule three controlled substances

Avg: 29%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 22%

$77
Average prescription price

Avg: $57

HAROLD ROTH D.O.

General Practice

11,427

$537K

313
207 are 65+

7%
patients receiving schedule two controlled substances

Avg: 8%

31%
patients receiving schedule three controlled substances

Avg: 29%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 22%

$47
Average prescription price

Avg: $57

JOHN VARGAS D.O.

General Practice

9,979

$629K

334
171 are 65+

15%
patients receiving schedule two controlled substances

Avg: 8%

52%
patients receiving schedule three controlled substances

Avg: 29%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 22%

$63
Average prescription price

Avg: $57

PETER NWOKE M.D

General Practice

9,693

$546K

454
133 are 65+

20%
patients receiving schedule two controlled substances

Avg: 8%

52%
patients receiving schedule three controlled substances

Avg: 29%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $57

BARRY BRAVER D.O.

General Practice

9,413

$424K

301
163 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

16%
patients receiving schedule three controlled substances

Avg: 29%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 22%

$45
Average prescription price

Avg: $57

ALAN SMIY MD

General Practice

9,222

$543K

777
610 are 65+

3%
patients receiving schedule two controlled substances

Avg: 8%

19%
patients receiving schedule three controlled substances

Avg: 29%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 22%

$59
Average prescription price

Avg: $57

CHARLES LEE D.O.

General Practice

9,054

$473K

203
104 are 65+

9%
patients receiving schedule two controlled substances

Avg: 8%

64%
patients receiving schedule three controlled substances

Avg: 29%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 22%

$52
Average prescription price

Avg: $57

JOEL MILLINER M.D.

General Practice

8,879

$727K

221
63 are 65+

36%
patients receiving schedule two controlled substances

Avg: 8%

55%
patients receiving schedule three controlled substances

Avg: 29%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 22%

$82
Average prescription price

Avg: $57

VICHA JANVIRIYA MD

General Practice

8,700

$291K

569
222 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

73%
patients receiving schedule three controlled substances

Avg: 29%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

15%
prescriptions for brand name drugs

Avg: 22%

$33
Average prescription price

Avg: $57

SANGITA PATEL

General Practice

8,585

$481K

253
110 are 65+

35%
patients receiving schedule two controlled substances

Avg: 8%

26%
patients receiving schedule three controlled substances

Avg: 29%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $57

TEODOR DANILIUC MD

General Practice

8,391

$584K

251
185 are 65+

10%
patients receiving schedule two controlled substances

Avg: 8%

24%
patients receiving schedule three controlled substances

Avg: 29%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 22%

$70
Average prescription price

Avg: $57

AARON GOLDFEIN M.D.

General Practice

7,880

$381K

294
118 are 65+

14%
patients receiving schedule two controlled substances

Avg: 8%

57%
patients receiving schedule three controlled substances

Avg: 29%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 22%

$48
Average prescription price

Avg: $57

SONJAI POONPANIJ MD

General Practice

7,561

$446K

718
195 are 65+

14%
patients receiving schedule two controlled substances

Avg: 8%

68%
patients receiving schedule three controlled substances

Avg: 29%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 22%

$59
Average prescription price

Avg: $57

VINOD KOHLI MD

General Practice

7,537

$299K

222
122 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

51%
patients receiving schedule three controlled substances

Avg: 29%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 22%

$40
Average prescription price

Avg: $57

RITA LANG D.O.

General Practice

7,431

$414K

240
213 are 65+

13%
patients receiving schedule two controlled substances

Avg: 8%

20%
patients receiving schedule three controlled substances

Avg: 29%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 22%

$56
Average prescription price

Avg: $57

MICHAEL MCNAMARA D.O.

General Practice

6,837

$550K

393
328 are 65+

6%
patients receiving schedule two controlled substances

Avg: 8%

23%
patients receiving schedule three controlled substances

Avg: 29%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 22%

$81
Average prescription price

Avg: $57

ADEKUNLE OSHIYOYE M.D.

General Practice

6,834

$283K

291
107 are 65+

26%
patients receiving schedule two controlled substances

Avg: 8%

58%
patients receiving schedule three controlled substances

Avg: 29%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 22%

$41
Average prescription price

Avg: $57

MICHAEL NWOKE M.D

General Practice

6,811

$399K

369
78 are 65+

76%
patients receiving schedule two controlled substances

Avg: 8%

5%
patients receiving schedule three controlled substances

Avg: 29%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 22%

$59
Average prescription price

Avg: $57

EMILIO BERRIOS ANTUNA M.D.

General Practice

6,807

$464K

172
40 are 65+

6%
patients receiving schedule two controlled substances

Avg: 8%

70%
patients receiving schedule three controlled substances

Avg: 29%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 22%

$68
Average prescription price

Avg: $57

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank